Detalles de la búsqueda
1.
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples.
Brief Bioinform
; 24(2)2023 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653909
2.
Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity.
Nucleic Acids Res
; 48(4): 1800-1810, 2020 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31930333
3.
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer.
Proc Natl Acad Sci U S A
; 116(52): 26823-26834, 2019 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826955
4.
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
Proc Natl Acad Sci U S A
; 114(22): E4482-E4491, 2017 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28507152
5.
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance.
Br J Cancer
; 120(3): 331-339, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30555156
6.
Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis.
BMC Cancer
; 19(1): 220, 2019 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871481
7.
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
Proc Natl Acad Sci U S A
; 113(43): E6600-E6609, 2016 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27791031
8.
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
Breast Cancer Res
; 16(5): 430, 2014 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25212826
9.
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial.
JCO Precis Oncol
; 8: e2300285, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427931
10.
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
NPJ Breast Cancer
; 10(1): 42, 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38851818
11.
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.
Clin Cancer Res
; 30(9): 1889-1905, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381406
12.
Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor-positive Breast Cancer.
Cancer Res Commun
; 3(11): 2331-2344, 2023 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37921419
13.
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer.
Cell Rep
; 42(8): 112821, 2023 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467106
14.
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Cancer Res
; 83(19): 3284-3304, 2023 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37450351
15.
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes.
Cytometry A
; 81(11): 960-72, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22791584
16.
Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer.
Clin Cancer Res
; 28(23): 5066-5078, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215125
17.
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Cancer Res
; 82(20): 3673-3686, 2022 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950920
18.
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.
Clin Cancer Res
; 27(17): 4870-4882, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33536276
19.
Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells.
Cancer Sci
; 101(7): 1661-9, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20491779
20.
A banking strategy toward customized therapy in breast cancer.
Cell Tissue Bank
; 10(4): 301-8, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19184530